Aspira women's health announces equity capital infusion of $3.06 million in private placement and warrant exercise

$2.95 million pipe $112 thousand warrant exercise austin, tx / access newswire / september 18, 2025 / aspira women's health inc. ("aspira") (otcqb:awhl), an ai enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostics and disease management tools, today announced that it has received equity capital totaling $3.06 million from existing and new investors. the company has entered into a securities purchase agreement dated september 18, 2025, pursuant to which the company has sold and issued an aggregate principal amount of $2.95 million in the form of a unit purchase, which includes common stock and a partial warrant (the "unit") in a private placement (the "private placement") with existing and new accredited investors, including members of the board of directors.
AWH Ratings Summary
AWH Quant Ranking